Greenwich lifesciences inc

Webabout. management team; board of directors; technology. our gp2 cancer immunotherapy product; cancer and immunotherapy background; clinical trials. completed phase iib clinical trial WebApr 13, 2024 · Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Rating) VP Jaye Thompson purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, April 11th.The shares were bought at an average price of $11.87 per share, for a total transaction of $11,870.00. Following the completion of the transaction, the vice president now owns …

Jaye Thompson Purchases 1,000 Shares of Greenwich LifeSciences, …

WebGet the latest Greenwich Lifesciences Inc (GLSI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebGreenwich LifeSciences, Inc. (GLSI) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 8 hours 49 minutes Dow Futures +7.00 Nasdaq Futures -80.50( … cian diagnostics frederick md https://prioryphotographyni.com

Does Greenwich Lifesciences Inc (GLSI) Have What it Takes to be …

WebLegal Name Greenwich LifeSciences, Inc. Stock Symbol NASDAQ:GLSI ; Company Type For Profit; Contact Email [email protected]; Phone Number (832) 819-3232; WebGreenwich LifeSciences, Inc. Daily – Vickers Top Insider Picks for 04/07/2024 The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 … WebMar 3, 2024 · Investor & Public Relations Contact for Greenwich LifeSciences Dave Gentry RedChip Companies Inc. Office: 1-800-RED CHIP (733 2447) Cell: (407) 491-4498 Email: [email protected] Release Summary ci and cd trong github

GLSI - Greenwich LifeSciences, Inc. Stock Price and Quote

Category:Greenwich LifeSciences, Inc. Announces Closing of Initial Public ...

Tags:Greenwich lifesciences inc

Greenwich lifesciences inc

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) VP Jaye Thompson …

WebApr 6, 2024 · A high-level overview of Greenwich LifeSciences, Inc. (GLSI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Greenwich lifesciences inc

Did you know?

WebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 1-year low of $6.82 and a 1-year high of $21.50. The stock has a market cap of $153.81 million, a PE ratio of -21.00 and a beta of 0.93. WebLegal Name Greenwich LifeSciences, Inc. Stock Symbol NASDAQ:GLSI ; Company Type For Profit; Contact Email [email protected]; Phone Number (832) 819 …

WebApr 14, 2024 · Greenwich LifeSciences has a 52-week low of $6.82 and a 52-week high of $21.50. The stock’s fifty day simple moving average is $14.92 and its 200-day simple … WebOct 4, 2024 · Business Wire. Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast …

WebSnehal S. Patel Chief Executive Officer. Over 30 years of experience in executive management, corporate development, operations, and investment banking in the … Web1 day ago · Item 8.01 Other Events. Greenwich LifeSciences, Inc. is confirming the following in light of the interest in both of its GP2 Phase IIb clinical trial and Phase III clinical trial, Flamingo-01: The... April 13, 2024

WebApr 14, 2024 · Greenwich LifeSciences has a 52-week low of $6.82 and a 52-week high of $21.50. The stock’s fifty day simple moving average is $14.92 and its 200-day simple moving average is $13.48. The...

WebFind real-time GLSI - Greenwich Lifesciences Inc stock quotes, company profile, news and forecasts from CNN Business. cia needs russian speakersWebApr 14, 2024 · On Friday, March 10th, Snehal Patel bought 1,000 shares of Greenwich LifeSciences stock. The stock was bought at an average cost of $12.12 per share, with a total value of $12,120.00. ci and cd in salesforceWebApr 10, 2024 · Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following … dfw weather windWebApr 13, 2024 · Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Rating) VP Jaye Thompson purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, … dfw weather winter stormWebApr 10, 2024 · Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients. ciandre taylorWebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 12-month low of $6.82 and a 12-month high of $21.50. The firm’s 50-day moving average price is $14.92 and its two-hundred day moving average price is $13.48. dfw weather updatesWebGreenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. … cia needs to be decrypted